Mike, an RCVS Queen’s Medal winner, will be in conversation with Catheryn Partington BVSc CertAVP(VC) MSc MRCVS, Jose Matos DVM DipECVIM (Cardiology) MRCVS European and RCVS Recognised Specialist in Small Animal Cardiology (canine and feline cardiology) and Paul Freeman MA, VetMB, Cert SAO, Dip ECVN, MRCVS (European and RCVS Specialist in Veterinary Neurology) (canine and feline neurology).
During the event, they will be explaining how Improve's new Academy Series can help vet professionals meet their annual CPD targets, learn through self-assessment and reflective study, and bring them to the forefront of medicine in several specialist areas.
Heber Alves, CEO of Improve International, said: “Here at Improve International, we are proud to be providing CPD training alongside the historic and prestigious University of Cambridge for our first Academy Series.
"We are excited to be working with many of its pioneering specialists at the Department of Veterinary Medicine and, as a former vet myself, I look forward to hearing how my fellow veterinarians handled the most difficult challenges of their careers.”
www.improveinternational.com
The new Improve Veterinary Academy Series is comprised of five month-long semesters, each of which will focus on a different clinical topic.
Each semester will consist of videoed lectures, discussion forums, journal clubs, as well as the ability to access the university’s latest evidence-based research in these areas.
The clinical topics to be explored are:
Each semester counts towards your annual CPD requirement.
Professor James Wood, Head of the Department of Veterinary Medicine at University of Cambridge, said: “This new partnership will allow veterinary nurses to get the latest evidence-based knowledge directly from our top specialists.
"They will also learn to apply valuable skills in their everyday practice life and engage with others on Improve International’s global, interactive online platform.
Charlotte French, Head of Curriculum & Quality at Improve International, said: “We are thrilled to be working with University of Cambridge Department of Veterinary Medicine as another innovative way to help the veterinary community take their careers to the next level.”
Professor Mike Herrtage, Trustee of the University of Cambridge Veterinary School Trust and former Dean of the Cambridge Veterinary School, said: “The new joint agreement brings together Improve International, with its outstanding record of high-quality and innovative CPD provision and the staff of the Department of Veterinary Medicine with their excellent specialist clinical knowledge and experience, as well as their recognised quality in small group teaching to stage the Improve International Academy Series.
"This will provide a new milestone in CPD course delivery.”
Apoquel chewable tablets were approved by the Veterinary Medicines Directorate (VMD) in November 2021.
Apoquel Chewable contains the same active ingredient, at the same dosing regime, for the same indications as original Apoquel, but in a palatable formulation which, in a field-study of client-owned dogs, was found to have a 91.6% acceptance rate.1
Dr Carly Mason, President of the British Veterinary Dermatology Study Group (BVDSG), said: “The new chewable form of Apoquel provides owners with a means of controlling itch using a tablet that can be given like a treat or mixed with a meal, making it much easier for owners and more acceptable to their pet.
“In many cases, the chewable formulation will be the obvious first-line Apoquel for veterinarians to prescribe to control canine itching while the underlying cause of allergic dermatitis is investigated.”
Reference
The study “Evaluation of quick sequential organ failure scores in dogs with severe sepsis and septic shock1” reviewed electronic records from dogs that presented through the veterinary medical teaching hospital emergency service between January 2010 and December 2019 using the search terms “sepsis” or “septic”.
The quick sequential organ failure score was calculated by evaluating respiratory rate (>22 breaths per minute), arterial systolic blood pressure (≤100mmHg) and altered mentation.
Forty-five dogs with severe sepsis and septic shock and 45 dogs with non-infectious systemic inflammatory response syndrome were included in the final analysis.
It was found that the quick sequential organ failure assessment score provided poor discrimination between survivors and non-survivors for dogs with severe sepsis and septic shock.
In addition, the quick sequential organ failure score demonstrated a poor sensitivity and fair specificity to detect this population of canine patients.
The authors say that previous studies on quick sequential organ failure score have provided conflicting results, but that this may just be due to the inherent heterogeneity of the population.
Considering the results of this study, it may not be possible to identify a single scoring system that serves the purpose that quick sequential organ failure assessment is intended for.
Nicola Di Girolamo, Editor of the JSAP said: “The results of this study have strong clinical implications.
"The JSAP values studies with negative findings such as this one, as much as studies with positive findings.
"The fact that a diagnostic tool or a treatment does not reach the desired objective, should not hinder publication of methodologically sound research”
https://onlinelibrary.wiley.com/doi/pdf/10.1111/jsap.13522
BVA President Malcolm Morley said: “Judging this competition has been genuinely both extremely enjoyable and really difficult.
"The entries this year have absolutely surpassed expectations and the level of talent on display is amazing.
"However, the photographs we have chosen are all well worthy of being finalists.
"From photos that made us laugh out loud, to others that made some of us feel close to tears, they evoked a range of emotions, but we were also impressed by the quality of the images, the creativity of the photographers and the composition of the photos, as well as the stories behind the lens.
The finalists are:
Vets at work
All creatures great and small
Happy pets that make us smile
The winners will be announced at BVA Live at Birmingham’s NEC in May, where this year there is also an opportunity for BVA Live delegates to vote for their favourite image from the shortlist, with a new ‘People’s Choice’ winner being announced in the weeks following the event.
At the heart of the new system is a transportable monitor (pictured right) which starts automatically after you connect two sensors and press the power button.
The system uses the handheld Darvall H100N Pulse Oximeter, which uses Nellcor OxiMax pulse oximetry technology.
It also comes with veterinary blood pressure NIBP small animal cuffs which are designed for accurate pressure detection in exotic animals, cats, and all sizes of dog.
Completing the Darvall Express system is the Darvall Capnograph which continuously measures the EtCO2 and respiratory rate, and features EtCO2 waveform Cardiac Oscillation artifact detection, for correct respiratory rate determination.
There's a default system set-up for cats and small dogs, a colour-coded display and a ten-hour battery life.
Darvall says the monitor has been thoroughly tested at veterinary practices in Australia, where it displayed outstanding performance in small dogs and cats, which are notoriously difficult to get reliable readings.
Darvall founder, Dr Colin Dunlop said: “Anaesthetic monitoring plays a vital role in keeping patients safe, giving peace of mind to the hospital veterinary team, and boosting pet owner confidence in the care their pet is receiving.
"This is vitally important when you remember mortality in veterinary patients is many times higher than in human hospital practice”.
http://www.aasmedical.co.uk
Hospital director David Walker said: “Ewan Ferguson has been providing our dermatology service for many years and with Hilary joining him, we will now be able to provide a full-time service to support our referring vets, their clients and pets.
He added: “We are really delighted that Hilary is joining the dermatology team at Anderson Moores. Her passion for dermatology is infectious and with a particular interest in chronic ear disease, I’m sure she’s going to be very busy!”
Hilary has been a past Board member and organiser of the scientific meetings for the British Veterinary Dermatology Study Group, a member of the In Practice editorial board for 20 years and a past chief examiner for the RCVS Small Animal Medicine Certificate. She continues to act as a mentor for the BSAVA PGCertSAM course and as an assessor for the RCVS Advanced Practitioner in Small Animal Dermatology.
Hilary has worked in first opinion and referral clinics around the south west, including running her own dermatology referral service within several veterinary practices. From 2018 to 2021, she had been working as lead clinician in dermatology at Langford Vets (University of Bristol).
Hilary said: “I’m very excited to be joining the fantastic team at Anderson Moores and really looking forward to helping make a difference with the new dermatology service we’ll be offering.
For more information, visit www.andersonmoores.com.
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
In addition, the Association is organising a number of other career events for nurses throughout the year:
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
Titled Nurses and Dermatology – the Bite Sized Guide to Getting Started, the series is presented by Frances Gaudiano, the RVN who wrote Veterinary Dermatology: A Manual for Nurses and Technicians.
Accounting for two hours’ CPD, the series is split into four 30-minute webinars covering:
Ceva is also including further training on its Douxo S3 range.
To pre-register for Nurses and Dermatology – the Bite Sized Guide to Getting Started, visit: https://www.thewebinarvet.com/pages/ceva-register-nurses-and-dermatology-bite-sized-guide/
The company is also hosting another series which is aimed at vets, but may also be of interest to nurses, called The Dermatology Extravaganza.
The Dermatology Extravaganza is presented by Dr Tim Nuttall, RCVS Specialist in Veterinary Dermatology and Head of Dermatology at The Royal (Dick) School of Veterinary Studies in Edinburgh and Dr Sarah Heath, RCVS and European Veterinary Specialist in Behavioural Medicine. The three sessions, which are between 30 minutes and an hour in length, will cover: ‘Topical therapy in canine atopic dermatitis’ and ‘Antimicrobial resistance’ presented by Dr Tim Nuttall and ‘Emotional considerations in dealing with dermatology cases’ by Dr Sarah Heath.
To register for The Dermatology Extravaganza, visit: https://www.thewebinarvet.com/pages/ceva-dermatology-tea-time-top-ups-bite-size-cpd-sessions/
All viewers will be able to enter into a prize draw to win a £50 Love2Shop voucher and a free Cytology Manual.
The new clinic is led by Marie Kubiak, an RCVS Specialist and diplomate in Zoo and Wildlife Medicine and one of only a small number Specialists that are accredited for reptiles, birds, pet mammals, wildlife, zoo species, fish and invertebrates.
The open day offers a chance to see the new clinic, meet the team, find out how it can support your practice and discuss any challenging cases you have.
Light snacks and drinks will be provided.
RSVP: evolutionexoticsreferrals@gmail.com
https://evolutionexoticsreferrals.co.uk
Evolution Exotics Referrals, Tenbury Road, Cleobury Mortimer, South Shropshire, DY14 0AD
The findings will be published in a freely-available and independently-authored report.
Jane Balmain, Chief Operating Officer at Vets4Pets (pictured right), said: “The last 18 months have been indescribably tough for everyone, not least the veterinary practice teams. Soaring levels of pet ownership coupled with recruitment challenges have meant that an already-stretched profession has been almost brought to its knees.
"As a profession, you’ve always put pets first. But now it’s time to also concentrate on you - the vets, nurses and support teams that make up our beloved sector. We want to hear how you’re feeling and give you the power to help us make change.
“By launching this sector-wide survey, we’re kick-starting a vital conversation to protect the wellbeing of vet teams and the future of the profession. We believe that, by sharing experiences openly and honestly from all corners of the sector, we can come together to bring about the much-needed changes to ensure it remains an attractive, long-term career option.”
The survey, which runs until 16th November 2021, can be completed at www.projectlisten.co.uk. Respondents will remain anonymous and no data will be collected via the survey.
Eight dogs being treated at three veterinary clinics in Norway took part in the study1.
Previous research2 has found a complication rate of 55% when fibreglass casts are used, 20% of them severe. In this study using the Upets Splinting System, only 12.5% of dogs (n=1) had complications that required treatment, and the complications were minor.
Dassiet says the results suggest that the new product has the potential to make veterinary casting safer, more sustainable, and can help control costs associated with cast replacement and treatment of complications.
86% of the veterinary surgeons participating in the study rated the Upets Splinting System as easy to use and said they would use the product on their own dog.
An earlier poll3 questioned vets on their most common concerns about casting and identified that the most significant were fear of complications (57%), the time-consuming nature of casting (54%) and inconvenience (51 %).
Dr. Martin Kaufmann, OrthoPets founder and Dassiet VET COO, said: “Complications often result from a cast that does not fit as well as it should.
"The results of this study suggest that Upets might be the ground-breaking tool that veterinarians have been waiting for as it provides them with the means to achieve a cast shape that is more precise."
For the white paper detailing the trial, visit: www.upets.vet/research.
References
Rosemullion Veterinary Practice is a three-site small animal practice owned by CVS.
It has 100 members of staff and dispenses 3,584 medications in an average month.
According to an article in Companion Animal, medication errors account for 30% of all reported errors in veterinary practice1.
Errors can be prescribing errors - where the vet prescribes the incorrect medication or dosage, or dispensing errors where the incorrect medication, strength or volume is dispensed by the pharmacy team.
Some errors can ‘look or sound alike’ – where medications have similar names or packaging – making them easy to mix up.
Rosemullion conducted an initial clinical audit of entries on its VetSafe system between 1st March and 31st May 2023.
Analysis was conducted on the drugs involved, whether they were prescribing or dispensing errors or near misses, and looking for patterns of behaviour or the drugs involved.
During this time there were 29 (0.27%) near misses and 14 (0.13%) errors.
Prescribing near misses most often involved flea and worm products.
Here additional feedback from vets was that it was difficult to remember weight brackets for all products and when weight brackets were included in the drug description this made them easier to prescribe accurately.
As a consequence, the Rosemullion pharmacy team introduced the inclusion of weight brackets on all flea and worm products.
Dispensing errors and near misses were mostly related to ‘look or sound alike’, particularly in worming tablets, flea treatments and Rheumocam cat and dog.
To address this, the Rosemullion pharmacy team added extra labelling to dispensary draws and separated draws for flea and worm treatments into different weight brackets.
Rheumocam – with its similar packaging design and box sizes – was also split into separate cat and dog drawers, and drawers clearly labelled up with the version and volume to make dispensing clearer.
Feedback was also given to the drug manufacturer.
Rosemullion also held a CPD session to highlight the common errors that were occurring, to explain resulting process and systems improvements, and ask the team to take extra care with these dispensaries.
A new ‘handing out medication’ process was also created – involving checking the medication in the bag matched the on the screen notes, confirming it was for the correct animal and validating it was what the owner was expecting.
A subsequent audit was run from 1st October to 31st November 2023.
The results revealed there were no prescribing or dispensing errors (0%) and only 8 (0.13%) near misses during this time.
Alice Bell, Senior Vet and Quality Improvement Lead at Rosemullion Veterinary Practice, said: “We place patient safety at the forefront of all we do.
"We wanted to conduct this extensive audit to assess our prescribing and dispensing processes and systems.
“The methods we had in place made it easy to do the task correctly and the changes we have now put in place have made the process even safer for our clients.
"Our overall error and near miss is now at a really low number compared to our total number of medication dispenses.
“The teams have been very receptive to the improvements and the project has had a positive impact on various aspects of the practice, including on team wellbeing.”
Rosemullion Veterinary Practice’s initiative has recently been recognised with a RCVS Knowledge Highly Commended status at its 2024 awards.
Sponsored by Vets4Pets, Sarah will look at ways the veterinary profession can improve the detection of this condition and enable you to offer practical advice and support for older animals and their owners.
Sarah is an RCVS and European Veterinary Specialist in Behavioural Medicine and was made a Fellow of the Royal College of Veterinary Surgeons in 2018.
She is a Certified Clinical Animal Behaviourist under the ASAB accreditation scheme and registered as a Veterinary Behaviourist with the Animal Behaviour and Training Council.
Dr Huw Stacey, Director of Clinical Services at Vets4Pets (pictured right) said: “Sadly, cognitive dysfunction is a progressive degenerative disease that can affect many of our beloved pets during their lifespan.
"However, various studies have shown that early intervention, using a combination of environmental, nutritional and medicinal approaches, can lead to significant improvement in quality of life.
“As part of our commitment to the wellbeing of pets, we are partnering with Sarah to sponsor this webinar and enable the entire industry to access the latest insights into early detection and proper management of the condition.
“Our aim is to help educate vets and nurses across the nation and empower them in their decision making when diagnosing elderly pets.”
The webinar will consist of a 45-minute webinar and 15-minute Q&A session.
It will count as one hour of CPD, and a recording will be available to attendees for a year following the event.
The webinar also forms part of a wider campaign which will see pet owners polled to ascertain their current understanding of the condition, and ultimately help to raise consumer awareness of cognitive dysfunction.
To register for a free place, visit: https://bit.ly/3IkuC9e
Pill Assist Cat is a soft treat pouch into which you insert a tablet, mould the pouch around the tablet and then feed to the cat.
Royal Canin says that in its tests, tablets were administered to cats successfully in 91% of cases using Pill Assist, which is not far off the 97% achieved with Pill Assist Dog which was launched earlier this year.
Erin Carr, Veterinary Marketing Executive at Royal Canin, said: "It’s an honour to be recognised by such an important industry body.
"Pill Assist Cat is set to launch next year. As with our Pill Assist Dog products, the aim is to make a real difference to pet’s health and wellbeing by turning pill time into a positive experience for both the pet and the owner."
Amy Scott MRCVS, Boehringer Ingehlheim’s performance horse portfolio manager, said: "Arti-Cell Forte is the first 'ready-to-use' stem cell-based product to be licensed in any veterinary species, and the only stem cell treatment to contain induced cells, representing a significant leap forward in both stem cell therapies and medicine as a whole.
"Arti-Cell Forte contains stem cells that have been chondrogenically induced and therefore primed to develop into the cartilage cell lineage. Studies have shown that chondrogenically induced stem cells demonstrate an enhanced clinical outcome compared to un-induced stem cells in the treatment of joint disease in horses¹."
"This makes Arti-Cell Forte a highly targeted and effective treatment for cartilage damage associated with degenerative joint disease."
Arti-Cell Forte is available direct from Boehringer Ingelheim to veterinary practitioners.
It needs to be stored at ultra-low temperatures to maintain its two year shelf life from manufacture, either frozen at -70 ⁰C to -90 ⁰C (dry ice, -80 ⁰C freezer) or -196 ⁰C (liquid nitrogen) until immediately prior to injecting.
The company is providing full training on storage and administration via face-to-face CPD at practice meetings or specific CPD events*.
For more information, contact your local territory manager or ring Boehringer's Technical Services Team on 01344 746957, or email vetenquiries@boehringer-ingelheim.com
For the study, titled “RHDV2 epidemic in UK pet rabbits. Part 1: clinical features, gross post mortem and histopathological findings”1, veterinary surgeons were encouraged to submit case histories and the results of post mortem examinations of pet rabbits that died suddenly. Samples taken during the post mortem were sent for histopathological examination.
Frances Harcourt-Brown, corresponding author for the paper, said: "Case histories, macroscopic findings and histopathology results were available from 300 rabbits that died suddenly.
"Of these, 185 (62%) died from RHD and showed characteristic histopathological features of RHD including apoptosis and variable lytic and coagulative hepatocellular necrosis, with varying distribution.
"Interestingly, macroscopic evidence of disease was not present in all cases – for example, gross liver abnormalities were only reported in 30% of cases, despite all cases showing hepatocellular necrosis on microscopic examination.
"Rapid death and death of other rabbits in the household were common features of RHD.
"Histopathology was also useful in yielding valuable information about other causes of death in the rabbits that did not die from RHD.”
Nicola Di Girolamo, editor of JSAP said: “This is a terrible disease that is currently spreading in areas of the world that were free from it until recently. Having more evidence on the type of clinical presentations and lesions that should be expected with this disease in rabbit patients is going to be of tremendous value for clinicians. Given that there is not always macroscopic evidence of RHD, histopathology is key for the diagnosis of RHD in pet rabbits.”
The full article can be found in the July issue of the Journal of Small Animal Practice which is free for BSAVA members.
It can also be read online here: https://www.onlinelibrary.wiley.com/doi/full/10.1111/jsap.13141
Photo: BSAVA
The ‘Introduction to the UK veterinary professions’ is a two-part online course run in partnership with VDS Training, designed to equip vets and nurses with the insight needed to work in the UK veterinary profession.
Due to the coronavirus pandemic, the course has been moved online. It includes a series of free online pre-recorded talks from representatives at a number of different veterinary organisations, including the RCVS, VDS Training, the British Veterinary Association, Vetlife, and VetAbroad.
The talks cover a variety of topics such as the Code of Professional Conduct, how to find the right job for you, how to look after mental health and wellbeing, and recognising and understanding cultural differences.
There will then be a number of live Question and Answer sessions across different dates over the coming months [see below], which are also free to attend, so those who have watched the videos can ask further questions from some of the speakers themselves.
Part 2 of the course is an optional practical and participatory paid-for online live communications skills training session run by VDS Training, looking at how to navigate some of the most common pitfalls encountered during client consultations, helping to equip you with the skills and confidence to communicate effectively in practice.
Ian Holloway, RCVS Director of Communications, said: “While we enjoyed running this course in person and meeting veterinary professionals from all over the world, the coronavirus pandemic has also given us the opportunity to look at how we can make this course even more accessible for a greater number of people.
“While there is still a significant live element, albeit online for the time being, the pre-recorded talks enable those veterinary surgeons and veterinary nurses to do much of the learning in their own time, without having to take time off work or travel to London for the day, meaning that more people can engage with this crucial information on working in the UK.”
Elly Russell MRCVS, a consultant at VDS Training, added: “Communicating with clients can be one of the most rewarding, but also challenging parts of our jobs as veterinary professionals. Communication problems lead to complaints, increase your stress at work and can impact the care our patients receive. Join VDS training for a highly interactive, online 4-hour workshop. Work in small groups with our experienced facilitators and role players using realistic scenarios to practise and develop your communication skills. Let us help you feel more confident managing common communication challenges in UK practice: improved communication will help you, your clients, and your patients.”
The dates for the free live 2021 Q&A sessions are:
The dates and times for the paid-for live online communications skills workshops from VDS Training are:
The cost for attending the communication skills session (Part 2) is £150 +VAT per person. It is not mandatory to complete both parts of the course, but those who are interested may choose the part of the course most suitable for them.
For further information: www.rcvs.org.uk/overseas-cpd
Nutraflex contains turmeric curcumin complex and boswellia extract, which Nutravet says work synergistically to support the natural systems that control inflammation.
The new product also contains glucosamine, a structural component of cartilage, and chondroitin sulphate to help maintain synovial fluid viscosity.
Nutravet claims the new product is fast acting, soothes stiff joints, aids long-term mobility, flexibility and joint structure, and supports the natural systems that control inflammation.
Chris Jones, Director at Nutravet said: “We’re delighted to be adding Nutraflex to our market-leading range of natural health products for pets.
"We’re always looking at ways of improving our products and Nutraflex provides our authorised stockists with a high strength veterinary exclusive joint support, supported by independent trial data, which works quickly to ultimately help pets that are suffering with joint stiffness.”
Nutraflex is available to order exclusively to authorised veterinary practices.
For more information, contact Nutravet on 0845 604 1688, email info@nutravet.co.uk or visit www.nutravet.com.
Cytopoint is an injectable monoclonal antibody therapy for dogs that targets and neutralises the cytokine IL-31, a mediator of allergic itch1.
Zoetis says the new claim was granted following a randomised, double-masked, multi-centred, placebo-controlled study which looked at Cytopoint’s efficacy and safety for the treatment of pruritus associated with allergic dermatitis in client-owned dogs. The study showed that Cytopoint significantly decreased pruritus, and improved skin lesions.2
Allison Henry, Product Manager Companion Animal Dermatology at Zoetis UK, says: "Allergic dermatitis is one of the most common skin conditions in dogs.3 The associated clinical signs – including scratching, hair loss and skin lesions – are disruptive for the dog, impacting their quality of life and that of its owner. Allergic skin disease is one of the most frequent reasons owners present their dog to a veterinarian.
"The licence extension demonstrates further innovation from Zoetis in the field of veterinary dermatology, and across the continuum of care, increasing the treatment options available to manage pruritus. Apoquel remains an ideal choice for short-term control due to its ability to provide rapid itch relief within four hours4 for as little as one day.5 This enables pruritus to be tightly controlled during the diagnostic work up,7 as well as being used for longer term control where tablets are the preferred method of administration.
"The sustained duration of action of Cytopoint makes it better suited to long-term management of pruritus, particularly when administering tablets is a challenge. Other benefits, such as no restrictions on age or with comorbidities, coupled with the flexibility of the new claim, make it a useful treatment at an earlier stage for more unique cases, e.g. young dogs or those with comorbidities."
For further information, contact your Zoetis Account Manager.
watch?v=A8EJ8LpLVzw
Specifically, remote assessments will make sure that practices are continuing to meet Veterinary Medicines Regulations, the Core Standards of the PSS and other key standards relating to the practice's accreditation type and level.
Mandisa Greene, RCVS President and Chair of the Practice Standards Group, said: “We have introduced these remote assessments as a means of being able to quality assure veterinary practices that are either in the Scheme or who wish to join it, while still making sure that public health is safeguarded and that the burden our face-to-face assessments may place on practices is reduced.
"All our Practice Standards Scheme Assessors will be trained in carrying out remote assessments, and practices that are due an assessment will be given the full details of how it will work in advance, just like if a physical assessment of the premises were taking place.
"In the immediate-term we will be prioritising those practices that were due assessment visits in March, April and May this year which were cancelled due to the nationwide lockdown and they are currently being contacted to make arrangements. We will then start a rolling programme of visits for the other delayed assessments over the next few months. We will aim to give all practices at least one month’s notice before a visit takes place."
In order to help veterinary teams at RCVS-accredited practices understand the changes and its implications, the RCVS has produced a list of anticipated FAQs containing the details of how remote assessments will work. These can be found at: www.rcvs.org.uk/setting-standards/practice-standards-scheme/remote-assessments.
Those with any additional enquiries should contact the RCVS Practice Standards Team on: pss@rcvs.org.uk.
The survey, which received over 1300 responses, found that the problem is more noticeable amongst locum vets (69% have worked when they’ve not felt well enough) and employees (64%) but is also an issue amongst partners and the self-employed (57%). It’s more common for vets in clinical practice (65%) than in non-clinical roles (51%). In all of these sectors over half of vets reported working when they were unwell.
18% of the vets surveyed said they do not take sick leave because they feel uncomfortable doing so. This is more common amongst younger vets (25% of under 35s compared to 19% of 35-54-year olds, and 8% of over 55s) and female vets (21% compared to 11% of male vets).
The main reasons given for not taking time off when sick are concerns about the impact on colleagues and worries about "letting the team down". One respondent said: "Because I would leave the practice understaffed and the remaining vets would have to work a lot harder and longer as a result." Another said: "Being ill is not an option. The practice is short staffed."
Members also reported a perceived culture of working through sickness. One said: "The veterinary industry on the whole has a 'phone in dead' policy ie don't call in sick!" and another said: "[I] feel that I am judged for taking time off, even when I lost my voice and was unable to consult."
A small number of responses (36 of the 450 vets who commented) mentioned that they did not receive sick pay or only received limited sick pay, so they avoided taking sick leave for financial reasons.
The BVA is reminding all vets that they have a legal right not to attend work when they aren’t well enough do so and that any concerns should be discussed with managers. The free BVA legal helpline is available to members to provide further guidance on taking sick leave.
BVA President Daniella Dos Santos said: "We know that veterinary workplaces are under enormous pressure from staff shortages, and none of us wants to feel like we are letting our colleagues down, but presenteeism only stores up more problems for the future.
"Working when you are ill puts your own health and wellbeing at risk longer term and can also put your colleagues, clients and patients under your care at risk.
"It’s particularly worrying that some of our colleagues feel pressure to work when they feel unwell, especially younger members. As a profession we have made huge steps forward in recognising the issues around mental health and supporting one another and being physically unwell should be the same.
“Anyone who is concerned should speak to their manager and remember that BVA members can always get free advice and support via the BVA legal helpline. Ultimately, it’s important to create a workplace culture that supports the entire veterinary team to prioritise their own physical and mental health."
Photo: Javier Brosch / Shutterstock
The research, conducted with the Blue Cross, analysed data from over 2,000 UK dog owners and identified perceptual barriers to welfare reforms.
The study revealed that many owners normalise health issues associated with brachycephalic conformations, including breathing difficulties, eye conditions, and skin infections.
One in seven owners of extreme brachycephalic dogs said that 'nothing' could dissuade them from owning these breeds, particularly those with a strong preference for flat faces and those that did not believe brachycephaly reduced a dog’s lifespan.
Owners of extreme brachycephalic dogs, such as French Bulldogs, found the perceived trait of 'laziness' to be highly desirable, despite the fact that an inability to exercise is often a symptom of brachycephalic obstructive airway syndrome (BOAS).
The researchers propose a series of interventions to overcome these barriers and make campaigning more effective, including:
Dr. Rowena Packer, lead researcher, said: "Future strategies to tackle the brachycephalic crisis must do more than presenting purely health-based data in generic public locations, and instead, positively offering possible alternate breeds, myth-busting false beliefs and leveraging human stories of brachycephalic owners to have greater impact.
"Additionally, specifically targeting these messages on social media and puppy-selling platforms may increase their efficacy.”
Game players have to 'catch' falling symbols marked with a '+' or the Credelio Plus ingredients, milbemycin oxime and lotilaner to win points, and avoid ones with fleas, ticks and worms, which lose points.
In addition to the £50 vouchers, there are goody packs for four runners up each month.
William Hawker, Parasiticides Marketing Manager at Elanco Animal Health said: "We are excited to showcase our novel new game at BVA Live with this exciting drop and offer all attendees the first chance to play Plus Plummet and win some great prizes by topping the leaderboard every month."
To play the game, visit: https://www.myelanco.co.uk/brand/plus-plummet
Incidentally, if you're at BVA Live, you're invited to join Elanco at the Exhibitor Showcase Theatre tomorrow from 09:00-09:50 for ‘Parasitology: Testing Times? Navigating the current challenges in practice’.
Cat Henstridge (BVSc MRCVS, small animal vet) will be interviewing Ian Wright (head of ESCCAP) and answering questions on everything from when to test, when to treat and how to communicate with pet owners about choice and the parasiticide treatment options available.
Photo: Elanco launches Plus Plummet at BVA Live
For the study “Comparative accuracy of two veterinary-calibrated point-of-care glucometres for measurement of blood glucose concentration in dogs” blood was sampled from client and staff-owned dogs above 6 months of age, of various breeds and health status.
The samples were then used to compare the accuracy of both PGBMs against a reference method - the hexokinase reaction method.
The authors say this was the first study to investigate AccuTell and the first published evidence comparing AlphaTrak2 with a reference method.
The study also sought to determine how useful the monitors are in clinical decision making and to assess the effect that packed cell volume (PCV) (known to affect the reliability of blood glucose concentration measurement in dogs) has on blood glucose concentration using the two PBGMs.
AccuTell was found to be more accurate and useful in a clinical setting than AlphaTrak2.
Both PBGMs were inaccurate in comparison with the hexokinase reaction method, and although they have potential for standard clinical use, unexpected blood glucose concentrations need to be checked by the hexokinase reaction method.
In addition, measurement of blood glucose concentration by the AlphaTrak2 was affected by PCV whereas measurement by the AccuTell was not.
Nicola Di Girolamo, Editor of JSAP said: “We oftentimes think that an instrument that is developed specifically for our patients will provide satisfactorily results on most occasions.
"Instead, studies such as the one presented here, are critical to understand whether the ‘numbers’ provided by an instrument are reliable for clinical use.
"The authors provided 95% limits of agreements to their results.
"This value is of great help for clinicians, since it shows the difference expected between the instrument and the reference standard in the majority of occasions.”
The study can be read online here: https://onlinelibrary.wiley.com/doi/epdf/10.1111/jsap.13491